267 related articles for article (PubMed ID: 19200852)
1. Activation of toll-like receptor signaling pathway for protection against influenza virus infection.
Wong JP; Christopher ME; Viswanathan S; Karpoff N; Dai X; Das D; Sun LQ; Wang M; Salazar AM
Vaccine; 2009 May; 27(25-26):3481-3. PubMed ID: 19200852
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis of acute respiratory virus infections using nucleic acid-based drugs.
Wong JP; Nagata LP; Christopher ME; Salazar AM; Dale RM
Vaccine; 2005 Mar; 23(17-18):2266-8. PubMed ID: 15755608
[TBL] [Abstract][Full Text] [Related]
3. Liposome-mediated immunotherapy against respiratory influenza virus infection using double-stranded RNA poly ICLC.
Wong JP; Yang H; Nagata L; Kende M; Levy H; Schnell G; Blasetti K
Vaccine; 1999 Mar; 17(13-14):1788-95. PubMed ID: 10194841
[TBL] [Abstract][Full Text] [Related]
4. Antiviral role of toll-like receptor-3 agonists against seasonal and avian influenza viruses.
Wong JP; Christopher ME; Viswanathan S; Dai X; Salazar AM; Sun LQ; Wang M
Curr Pharm Des; 2009; 15(11):1269-74. PubMed ID: 19355966
[TBL] [Abstract][Full Text] [Related]
5. Activation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model.
Boukhvalova MS; Sotomayor TB; Point RC; Pletneva LM; Prince GA; Blanco JC
J Interferon Cytokine Res; 2010 Apr; 30(4):229-42. PubMed ID: 20038196
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic, therapeutic and immune enhancement effect of liposome-encapsulated PolyICLC on highly pathogenic H5N1 influenza infection.
Li Y; Hu Y; Jin Y; Zhang G; Wong J; Sun LQ; Wang M
J Gene Med; 2011 Jan; 13(1):60-72. PubMed ID: 21259409
[TBL] [Abstract][Full Text] [Related]
7. Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models.
Zhu X; Nishimura F; Sasaki K; Fujita M; Dusak JE; Eguchi J; Fellows-Mayle W; Storkus WJ; Walker PR; Salazar AM; Okada H
J Transl Med; 2007 Feb; 5():10. PubMed ID: 17295916
[TBL] [Abstract][Full Text] [Related]
8. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans.
Caskey M; Lefebvre F; Filali-Mouhim A; Cameron MJ; Goulet JP; Haddad EK; Breton G; Trumpfheller C; Pollak S; Shimeliovich I; Duque-Alarcon A; Pan L; Nelkenbaum A; Salazar AM; Schlesinger SJ; Steinman RM; Sékaly RP
J Exp Med; 2011 Nov; 208(12):2357-66. PubMed ID: 22065672
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice.
Wong JP; Saravolac EG; Sabuda D; Levy HB; Kende M
Antimicrob Agents Chemother; 1995 Nov; 39(11):2574-6. PubMed ID: 8585749
[TBL] [Abstract][Full Text] [Related]
10. Nucleic acid-based antiviral drugs against seasonal and avian influenza viruses.
Wong JP; Christopher ME; Salazar AM; Dale RM; Sun LQ; Wang M
Vaccine; 2007 Apr; 25(16):3175-8. PubMed ID: 17280757
[TBL] [Abstract][Full Text] [Related]
11. Novel antiviral therapeutics to control foot-and-mouth disease.
Dias CC; Moraes MP; Weiss M; Diaz-San Segundo F; Perez-Martin E; Salazar AM; de los Santos T; Grubman MJ
J Interferon Cytokine Res; 2012 Oct; 32(10):462-73. PubMed ID: 22924938
[TBL] [Abstract][Full Text] [Related]
12. Poly-ICLC preconditioning protects the blood-brain barrier against ischemic injury in vitro through type I interferon signaling.
Gesuete R; Packard AE; Vartanian KB; Conrad VK; Stevens SL; Bahjat FR; Yang T; Stenzel-Poore MP
J Neurochem; 2012 Nov; 123 Suppl 2(Suppl 2):75-85. PubMed ID: 23050645
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.
Kumaki Y; Day CW; Smee DF; Morrey JD; Barnard DL
Antiviral Res; 2011 Nov; 92(2):329-40. PubMed ID: 21925541
[TBL] [Abstract][Full Text] [Related]
14. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
[TBL] [Abstract][Full Text] [Related]
15. Interferon protects mice against inhalation anthrax.
Walberg K; Baron S; Poast J; Schwartz B; Izotova L; Pestka S; Peterson JW
J Interferon Cytokine Res; 2008 Oct; 28(10):597-601. PubMed ID: 18778201
[TBL] [Abstract][Full Text] [Related]
16. Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.
Ichinohe T; Tamura S; Kawaguchi A; Ninomiya A; Imai M; Itamura S; Odagiri T; Tashiro M; Takahashi H; Sawa H; Mitchell WM; Strayer DR; Carter WA; Chiba J; Kurata T; Sata T; Hasegawa H
J Infect Dis; 2007 Nov; 196(9):1313-20. PubMed ID: 17922395
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor agonists shape the immune responses to a mannose receptor-targeted cancer vaccine.
He LZ; Weidlick J; Sisson C; Marsh HC; Keler T
Cell Mol Immunol; 2015 Nov; 12(6):719-28. PubMed ID: 25345808
[TBL] [Abstract][Full Text] [Related]
18. Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial.
Saxena M; Sabado RL; La Mar M; Mohri H; Salazar AM; Dong H; Correa Da Rosa J; Markowitz M; Bhardwaj N; Miller E
Front Immunol; 2019; 10():725. PubMed ID: 31024557
[No Abstract] [Full Text] [Related]
19. The efficacy of poly-ICLC against Ebola-Zaire virus (EBOV) infection in mice and cynomolgus monkeys.
Kende M; Paragas J; Salazar AM
Antiviral Res; 2019 Mar; 163():179-184. PubMed ID: 30611774
[TBL] [Abstract][Full Text] [Related]
20. Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections.
Guerrero-Plata A; Baron S; Poast JS; Adegboyega PA; Casola A; Garofalo RP
J Virol; 2005 Aug; 79(16):10190-9. PubMed ID: 16051812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
